Invesco Ltd. - PARATEK PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Invesco Ltd. ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$40,770
+106.7%
16,051
+52.1%
0.00%
Q4 2022$19,729
-63.5%
10,550
-42.1%
0.00%
Q1 2022$54,000
-31.6%
18,211
+4.4%
0.00%
Q4 2021$79,000
-12.2%
17,446
-5.6%
0.00%
Q3 2021$90,000
-9.1%
18,484
+27.2%
0.00%
Q2 2021$99,000
-87.2%
14,534
-89.8%
0.00%
Q3 2020$771,000
-79.9%
142,486
-6.7%
0.00%
-100.0%
Q3 2017$3,834,000
-53.8%
152,754
-55.6%
0.00%
-66.7%
Q2 2017$8,300,000
+22955.6%
344,399
+24239.2%
0.00%
Q2 2015$36,0001,4150.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders